Source / episode info
- **Episode:**79
- **Title:**Divine Intervention Episode 79 – USMLE Step 1 Hematology Part 1
- **Published:**2019-02-14
- Source:Episode page
One-liner
This episode provides a deep dive into hematology, covering platelet disorders (vWD, Glanzmann's, ITP), detailing the two phases of hemostasis—primary (platelet plug) and secondary (fibrin clot)—and reviewing the complex coagulation cascade factors and associated anticoagulant pathways.
High-yield summary
- Primary Hemostasis: Involves platelet adhesion to exposed subendothelial collagen via the {vWF} -> {GP IIb/IIIa} interaction, forming a weak platelet plug.
- Secondary Hemostasis: Stabilizes the plug by converting fibrinogen (Factor I) into stable fibrin ({Fibrin}_{{stable}}), primarily driven by Thrombin ({IIa}) and cross-linked by Factor XIII.
- Antiplatelet Drugs: Aspirin is an antiplatelet drug because it irreversibly inhibits {COX}, preventing the formation of {Thromboxane A}_2 ({TXA}_2), thereby inhibiting platelet aggregation (primary hemostasis).
- Coagulation Monitoring: The Extrinsic pathway is monitored by PT/INR (Factors VII, X, V, II); the Intrinsic pathway is monitored by aPTT (Factors XII, XI, IX, VIII, X, V, II).
- Protein C System: Factor {II} binding to Thrombomodulin activates Protein C. Activated Protein C pairs with Protein S to inactivate Factors {Va} and {VIIIa}, providing a negative feedback loop for coagulation.
Learning objectives
- Differentiate the pathophysiology and diagnostic testing for common inherited bleeding disorders (e.g., vWD vs. Glanzmann's).
- Describe the sequential steps of primary hemostasis (adhesion -> aggregation) and secondary hemostasis (fibrin stabilization).
- Identify key antiplatelet drugs (Aspirin, P2Y12 inhibitors) and their specific molecular targets (\text{COX}, ADP receptor).
- Interpret coagulation screening tests (PT/INR vs. aPTT) to localize factor deficiencies within the intrinsic or extrinsic pathways.
- Explain the role of natural anticoagulants (Protein C, Protein S, Antithrombin III) in regulating the coagulation cascade via negative feedback loops.
Board exam buzzwords